secwatch.observer — SEC 8-K summary
======================================

Issuer:     Voyager Therapeutics, Inc. (VYGR)
CIK:        0001640266
Form:       8-K
Filed at:   2022-07-28T23:59:59+00:00
Accession:  0001104659-22-083431
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Voyager Therapeutics appoints Catherine J. Mackey, Ph.D. to Board of Directors
------------------------------------------------------------------------------

- Dr. Mackey appointed as Class I director effective August 15, 2022, serving until 2025 annual meeting.
- She joins the Audit Committee and Science and Technology Committee.
- Annual cash retainers: $40,000 for Board, $8,000 for Audit, $5,000 for Science & Technology.
- Receives initial option for 44,000 shares vesting quarterly over 4 years; annual option for 22,000 shares thereafter.
- Dr. Mackey previously was SVP at Pfizer and serves on other biotech boards (IDEAYA, Avid Bioservices, Cour Pharmaceuticals).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1640266/000110465922083431/0001104659-22-083431-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1640266/000110465922083431/tm2221989d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-083431

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer